Rapafusyn Pharmaceuticals
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- $44M
Investors
- 5
About Rapafusyn Pharmaceuticals
Based in Maryland, US, and founded in 2015 by Jun O. Liu, PhD, Rapafusyn Pharmaceuticals operates as a provider of FKBP-binding macrocyclic peptides for targeting intracellular and transmembrane proteins to drug developers. Hu, PhD, MBA. The company provides a wide range of drug discovery products, such as DNA-encoded libraries (DELs), arrayed libraries of non-degrading molecular glues (RapaGlues), large DNA-encoded libraries (DELs), and arrayed libraries of FKBP-binding macrocyclic peptides. Moreover, the firm offers drug discovery solutions targeting intracellular proteins and transmembrane domains like SLCs and GPCRs. Additionally, the company also provides services such as rapid SAR expansion for improving potency, selectivity, and physiochemical properties. The company generates revenue through providing its products, such as DNA-encoded libraries (DELs), arrayed libraries of non-degrading molecular glues (RapaGlues), large DNA-encoded libraries (DELs), and arrayed libraries of FKBP-binding macrocyclic peptides. The company will support product innovation and improve business operations.
Who invested in Rapafusyn Pharmaceuticals
5 investors across 1 round
See all investors in Rapafusyn Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 5, 2025
Amount
$44M
Investors
Questions about Rapafusyn Pharmaceuticals
Who invested in Rapafusyn Pharmaceuticals?
Rapafusyn Pharmaceuticals has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rapafusyn Pharmaceuticals raised?
Rapafusyn Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Rapafusyn Pharmaceuticals last raise money?
Rapafusyn Pharmaceuticals's most recent round on record is a Series A, in Sep 2025.
What does Rapafusyn Pharmaceuticals do?
Based in Maryland, US, and founded in 2015 by Jun O.
Where is Rapafusyn Pharmaceuticals headquartered?
Rapafusyn Pharmaceuticals is headquartered in Baltimore, US.
Which VCs invest in companies like Rapafusyn Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rapafusyn Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Rapafusyn Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.